# Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

> **NCT00843193** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 198 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** INTRAVENOUS GSK679586
- **DRUG:** INTRAVENOUS PLACEBO
- **DRUG:** FLUTICASONE PROPIONATE

## Key facts

- **NCT ID:** NCT00843193
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-09
- **Primary completion:** 2010-07-25
- **Final completion:** 2010-07-25
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843193, "Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00843193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*